Cargando…
Drug pipeline 2Q22 — a downturn in approvals
Autor principal: | DeFrancesco, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361956/ https://www.ncbi.nlm.nih.gov/pubmed/35945433 http://dx.doi.org/10.1038/s41587-022-01413-z |
Ejemplares similares
-
2Q22 — Slip sliding away
por: DeFrancesco, Laura
Publicado: (2022) -
Managing IT in a downturn
por: Mitchell, Stewart
Publicado: (2008) -
Artifacts: The downturn of CBCT image
por: Nagarajappa, Anil Kumar, et al.
Publicado: (2015) -
Training the Next Generation of Translational Cardiovascular Investigators: Is the Pipeline Half Full or Half Empty?
por: Nerbonne, Jeanne M., et al.
Publicado: (2016) -
Silver lining: your guide to innovating in a downturn
por: Anthony, Scott D
Publicado: (2009)